{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:59:08Z","timestamp":1793757548319,"version":"4.6.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016132","name":"Gouvernement Wallon","doi-asserted-by":"crossref","award":["8312"],"award-info":[{"award-number":["8312"]}],"id":[{"id":"10.13039\/100016132","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016132","name":"Gouvernement Wallon","doi-asserted-by":"crossref","award":["8312"],"award-info":[{"award-number":["8312"]}],"id":[{"id":"10.13039\/100016132","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>During cell death, nucleosomes, the basic structural unit of chromatin, are released into the blood stream and elevated levels have been found in the plasma of patients with solid cancers. In this study, we demonstrate an increase in cell free circulating H3.1-nucleosomes levels in plasma samples from patients with hematological malignancy, non-Hodgkin lymphoma (NHL), relative to healthy donors. As histone post-translational modifications (PTMs) of circulating nucleosomes are described as potential biomarkers of various solid cancers, we investigated the epigenetic profile of nucleosomes from NHL patients following nucleosome enrichment (Nu.Q\u00ae capture) combined with mass spectrometry. Eight histones PTMs, including the acetylation of histone H3 at lysine 9, 14 and 18 as well as the methylation state of histone H3 at lysine 9, 27 and 36, were identified at a higher level in the plasma of NHL patients compared to healthy donors. These results were confirmed in a larger clinical cohort by immunoassay. Subsequently, the temporal profile of these histone PTMs in NHL patients undergoing treatment course highlighted the potential use of these new biomarkers to monitor treatment response and\/or disease progression. Our results substantiate that levels of H3.1-nucleosomes are particularly elevated in NHL patients and may be a useful diagnostic tool. Moreover, our work emphasizes the crucial roles of the epigenetic marks present on circulating nucleosomes to detect and monitor tumor progression and\/or treatment response of non-Hodgkin Lymphoma.<\/jats:p>","DOI":"10.1038\/s41598-023-43520-0","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T10:02:23Z","timestamp":1695895343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma"],"prefix":"10.1038","volume":"13","author":[{"given":"Priscilla","family":"Van den Ackerveken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Lobbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"Pamart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristotelis","family":"Kotronoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Rommelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Eccleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"43520_CR1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1521-4141(200103)31:3<743::AID-IMMU743>3.0.CO;2-9","volume":"31","author":"M Oliveri","year":"2001","unstructured":"Oliveri, M. et al. DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis. Eur. J. Immunol. 31, 743\u2013751 (2001).","journal-title":"Eur. J. Immunol."},{"key":"43520_CR2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz, P. & Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15, 703\u2013708 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"43520_CR3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705 (2007).","journal-title":"Cell"},{"key":"43520_CR4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.51.5.786","volume":"51","author":"VG Allfrey","year":"1964","unstructured":"Allfrey, V. G., Faulkner, R. & Mirsky, A. E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. 51, 786\u2013794 (1964).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"43520_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.leu.2400579","volume":"11","author":"B Martinez-Delgado","year":"1997","unstructured":"Martinez-Delgado, B. et al. Hypermethylation of a 5\u2032 CpG island of p16 is a frequent event in non-Hodgkin\u2019s lymphoma. Leukemia 11, 425\u2013428 (1997).","journal-title":"Leukemia"},{"key":"43520_CR6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1309\/LCGNV77J464LNFD6","volume":"124","author":"J Guo","year":"2005","unstructured":"Guo, J. et al. Differential DNA methylation of gene promoters in small B-cell lymphomas. Am. J. Clin. Pathol. 124, 430\u2013439 (2005).","journal-title":"Am. J. Clin. Pathol."},{"key":"43520_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2217\/epi.13.39","volume":"5","author":"MR Hassler","year":"2013","unstructured":"Hassler, M. R., Schiefer, A.-I. & Egger, G. Combating the epigenome: Epigenetic drugs against non-Hodgkin\u2019s lymphoma. Epigenomics 5, 397\u2013415 (2013).","journal-title":"Epigenomics"},{"key":"43520_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","volume":"1","author":"S Ropero","year":"2007","unstructured":"Ropero, S. & Esteller, M. The role of histone deacetylases (HDACs) in human cancer. Mol. Oncol. 1, 19\u201325 (2007).","journal-title":"Mol. Oncol."},{"key":"43520_CR9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2016-08-733469","volume":"129","author":"I Garc\u00eda-Ram\u00edrez","year":"2017","unstructured":"Garc\u00eda-Ram\u00edrez, I. et al. Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice. Blood 129, 2645\u20132656 (2017).","journal-title":"Blood"},{"key":"43520_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci, L. et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189\u2013195 (2011).","journal-title":"Nature"},{"key":"43520_CR11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.7150\/ijms.8522","volume":"11","author":"SH Lee","year":"2014","unstructured":"Lee, S. H. et al. Expression of histone deacetylases in diffuse large B-cell lymphoma and its clinical significance. Int. J. Med. Sci. 11, 994\u20131000 (2014).","journal-title":"Int. J. Med. Sci."},{"key":"43520_CR12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10637-010-9591-3","volume":"28","author":"J Zain","year":"2010","unstructured":"Zain, J. & O\u2019Connor, O. A. Targeting histone deacetyalses in the treatment of B- and T-cell malignancies. Investig. New Drugs 28, 58\u201378 (2010).","journal-title":"Investig. New Drugs"},{"key":"43520_CR13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s13238-020-00694-x","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma. Protein Cell 11, 472\u2013482 (2020).","journal-title":"Protein Cell"},{"key":"43520_CR14","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.18632\/oncotarget.21908","volume":"9","author":"L Rasmussen","year":"2018","unstructured":"Rasmussen, L., Christensen, I. J., Herzog, M., Micallef, J. & Nielsen, H. J. Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer. Oncotarget 9, 10247\u201310258 (2018).","journal-title":"Oncotarget"},{"key":"43520_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-021-01741-5","volume":"21","author":"S Punia","year":"2021","unstructured":"Punia, S. et al. Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers. BMC Gastroenterol. 21, 149 (2021).","journal-title":"BMC Gastroenterol."},{"key":"43520_CR16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1078-0432.CCR-19-2533","volume":"26","author":"SJ Bagley","year":"2020","unstructured":"Bagley, S. J. et al. Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: A pilot prospective study. Clin. Cancer Res. 26, 397\u2013407 (2020).","journal-title":"Clin. Cancer Res."},{"key":"43520_CR17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/annonc\/mdp006","volume":"20","author":"S Hohaus","year":"2009","unstructured":"Hohaus, S. et al. Cell-free circulating DNA in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas. Ann. Oncol. 20, 1408\u20131413 (2009).","journal-title":"Ann. Oncol."},{"key":"43520_CR18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5045\/br.2019.54.2.114","volume":"54","author":"M Eskandari","year":"2019","unstructured":"Eskandari, M., Manoochehrabadi, S., Pashaiefar, H., Zaimy, M. A. & Ahmadvand, M. Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma. Blood Res. 54, 114\u2013119 (2019).","journal-title":"Blood Res."},{"key":"43520_CR19","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00277-020-04008-3","volume":"99","author":"JY Hur","year":"2020","unstructured":"Hur, J. Y. et al. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas. Ann. Hematol. 99, 1293\u20131302 (2020).","journal-title":"Ann. Hematol."},{"key":"43520_CR20","doi-asserted-by":"crossref","first-page":"29654","DOI":"10.3390\/ijms161226180","volume":"16","author":"U Gezer","year":"2015","unstructured":"Gezer, U. et al. Histone methylation marks on circulating nucleosomes as novel blood-based biomarker in colorectal cancer. Int. J. Mol. Sci. 16, 29654\u201329662 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"43520_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13148-017-0351-5","volume":"9","author":"J-F Rahier","year":"2017","unstructured":"Rahier, J.-F. et al. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer. Clin. Epigenet. 9, 53 (2017).","journal-title":"Clin. Epigenet."},{"key":"43520_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13148-015-0139-4","volume":"7","author":"M Bauden","year":"2015","unstructured":"Bauden, M. et al. Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer. Clin. Epigenet. 7, 106 (2015).","journal-title":"Clin. Epigenet."},{"key":"43520_CR23","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1038\/s41598-021-86630-3","volume":"11","author":"P Van den Ackerveken","year":"2021","unstructured":"Van den Ackerveken, P. et al. A novel proteomics approach to epigenetic profiling of circulating nucleosomes. Sci. Rep. 11, 7256 (2021).","journal-title":"Sci. Rep."},{"key":"43520_CR24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/febs.15707","volume":"289","author":"R Noberini","year":"2022","unstructured":"Noberini, R., Robusti, G. & Bonaldi, T. Mass spectrometry-based characterization of histones in clinical samples: Applications, progress, and challenges. FEBS J. 289, 1191\u20131213 (2022).","journal-title":"FEBS J."},{"key":"43520_CR25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1105\/tpc.15.01003","volume":"28","author":"S Otero","year":"2016","unstructured":"Otero, S., Desvoyes, B., Peir\u00f3, R. & Gutierrez, C. Histone H3 dynamics reveal domains with distinct proliferation potential in the Arabidopsis root. Plant Cell. 28, 1361\u20131371 (2016).","journal-title":"Plant Cell."},{"key":"43520_CR26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/jcp.55.9.648","volume":"55","author":"L Leoncini","year":"2002","unstructured":"Leoncini, L. Cell kinetics and cell cycle regulation in lymphomas. J. Clin. Pathol. 55, 648\u2013655 (2002).","journal-title":"J. Clin. Pathol."},{"key":"43520_CR27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/138920208785699580","volume":"9","author":"B Sadikovic","year":"2008","unstructured":"Sadikovic, B., Al-Romaih, K., Squire, J. & Zielenska, M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr. Genom. 9, 394\u2013408 (2008).","journal-title":"Curr. Genom."},{"key":"43520_CR28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: An open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968 (2010).","journal-title":"Bioinformatics"},{"key":"43520_CR29","first-page":"143","volume":"19","author":"K Kuroi","year":"2001","unstructured":"Kuroi, K., Tanaka, C. & Toi, M. Clinical significance of plasma nucleosome levels in cancer patients. Int. J. Oncol. 19, 143\u2013148 (2001).","journal-title":"Int. J. Oncol."},{"key":"43520_CR30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1448.012","volume":"1137","author":"S Holdenrieder","year":"2008","unstructured":"Holdenrieder, S. et al. Clinical relevance of circulating nucleosomes in cancer. Ann. N. Y. Acad. Sci. 1137, 180\u2013189 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"43520_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cancers9010005","volume":"9","author":"P McAnena","year":"2017","unstructured":"McAnena, P., Brown, J. & Kerin, M. Circulating nucleosomes and nucleosome modifications as biomarkers in cancer. Cancers (Basel) 9, 5 (2017).","journal-title":"Cancers (Basel)"},{"key":"43520_CR32","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/biom13081255","volume":"13","author":"E Grolleau","year":"2023","unstructured":"Grolleau, E. et al. Circulating H3K27 methylated nucleosome plasma concentration: synergistic information with circulating tumor DNA molecular profiling. Biomolecules 13, 1255 (2023).","journal-title":"Biomolecules"},{"key":"43520_CR33","doi-asserted-by":"crossref","first-page":"eaat6753","DOI":"10.1126\/scisignal.aat6753","volume":"11","author":"AI Salter","year":"2018","unstructured":"Salter, A. I. et al. Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. Sci. Signal 11, eaat6753 (2018).","journal-title":"Sci. Signal"},{"key":"43520_CR34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.ajpath.2014.01.036","volume":"184","author":"D Rolland","year":"2014","unstructured":"Rolland, D. et al. Global phosphoproteomic profiling reveals distinct signatures in B-cell non-hodgkin lymphomas. Am. J. Pathol. 184, 1331\u20131342 (2014).","journal-title":"Am. J. Pathol."},{"key":"43520_CR35","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1074\/mcp.M500112-MCP200","volume":"4","author":"RR Miles","year":"2005","unstructured":"Miles, R. R., Crockett, D. K., Lim, M. S. & Elenitoba-Johnson, K. S. J. Analysis of BCL6-interacting proteins by tandem mass spectrometry. Mol. Cell. Proteomics 4, 1898\u20131909 (2005).","journal-title":"Mol. Cell. Proteomics"},{"key":"43520_CR36","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood-2018-02-831438","volume":"132","author":"X Lu","year":"2018","unstructured":"Lu, X. et al. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival. Blood 132, 2026\u20132039 (2018).","journal-title":"Blood"},{"key":"43520_CR37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2559.2009.03290.x","volume":"54","author":"L Marquard","year":"2009","unstructured":"Marquard, L. et al. Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas. Histopathology 54, 688\u2013698 (2009).","journal-title":"Histopathology"},{"key":"43520_CR38","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/onc.2010.579","volume":"30","author":"JA Anderton","year":"2011","unstructured":"Anderton, J. A. et al. The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin\u2019s Lymphoma. Oncogene 30, 2037\u20132043 (2011).","journal-title":"Oncogene"},{"key":"43520_CR39","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3390\/cancers13081930","volume":"13","author":"K Dunphy","year":"2021","unstructured":"Dunphy, K., Dowling, P., Bazou, D. & O\u2019Gorman, P. Current methods of post-translational modification analysis and their applications in blood cancers. Cancers (Basel) 13, 1930 (2021).","journal-title":"Cancers (Basel)"},{"key":"43520_CR40","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/elps.200305457","volume":"24","author":"F Antonucci","year":"2003","unstructured":"Antonucci, F. et al. Two-dimensional molecular profiling of mantle cell lymphoma. Electrophoresis. 24, 2376\u20132385 (2003).","journal-title":"Electrophoresis."},{"key":"43520_CR41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jchromb.2016.11.005","volume":"1047","author":"K Psatha","year":"2017","unstructured":"Psatha, K. et al. Deciphering lymphoma pathogenesis via state-of-the-art mass spectrometry-based quantitative proteomics. J. Chromatogr. B 1047, 2\u201314 (2017).","journal-title":"J. Chromatogr. B"},{"key":"43520_CR42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach, H., Hoon, D. S. B. & Pantel, K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426\u2013437 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"43520_CR43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12917-021-02991-x","volume":"17","author":"C Dolan","year":"2021","unstructured":"Dolan, C. et al. Characterizing circulating nucleosomes in the plasma of dogs with lymphoma. BMC Vet. Res. 17, 276 (2021).","journal-title":"BMC Vet. Res."},{"key":"43520_CR44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy, A. et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell 171, 481-494.e15 (2017).","journal-title":"Cell"},{"key":"43520_CR45","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1158\/0008-5472.CAN-17-0701","volume":"77","author":"G Rodr\u00edguez-Hern\u00e1ndez","year":"2017","unstructured":"Rodr\u00edguez-Hern\u00e1ndez, G. et al. Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases. Cancer Res. 77, 4365\u20134377 (2017).","journal-title":"Cancer Res."},{"key":"43520_CR46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/cells8050485","volume":"8","author":"M Ha\u0142asa","year":"2019","unstructured":"Ha\u0142asa, M. et al. H3K18Ac as a marker of cancer progression and potential target of anti-cancer therapy. Cells 8, 485 (2019).","journal-title":"Cells"},{"key":"43520_CR47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2011.06.182","volume":"411","author":"C Puppin","year":"2011","unstructured":"Puppin, C. et al. Levels of histone acetylation in thyroid tumors. Biochem. Biophys. Res. Commun. 411, 679\u2013683 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"43520_CR48","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.3390\/ijms221810055","volume":"22","author":"D Bajusz","year":"2021","unstructured":"Bajusz, D., Bogn\u00e1r, Z., Ebner, J., Grebien, F. & Keser\u0171, G. M. Discovery of a non-nucleoside SETD2 methyltransferase inhibitor against acute myeloid leukemia. Int. J. Mol. Sci. 22, 10055 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"43520_CR49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41388-018-0474-y","volume":"38","author":"A Swaroop","year":"2019","unstructured":"Swaroop, A. et al. An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia. Oncogene 38, 671\u2013686 (2019).","journal-title":"Oncogene"},{"key":"43520_CR50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3816\/CLM.2006.n.005","volume":"6","author":"M Meignan","year":"2006","unstructured":"Meignan, M., Haioun, C., Itti, E., Rahmouni, A. & Reyes, F. Value of [18F]fluorodeoxyglucose\u2013positron emission tomography in managing adults with aggressive non-Hodgkin\u2019s lymphoma. Clin. Lymphoma Myeloma 6, 306\u2013313 (2006).","journal-title":"Clin. Lymphoma Myeloma"},{"key":"43520_CR51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ijc.11003","volume":"104","author":"C Trejo-Becerril","year":"2003","unstructured":"Trejo-Becerril, C. et al. Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients. Int. J. Cancer 104, 663\u2013668 (2003).","journal-title":"Int. J. Cancer"},{"key":"43520_CR52","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1158\/1078-0432.CCR-04-0625","volume":"10","author":"S Holdenrieder","year":"2004","unstructured":"Holdenrieder, S. et al. Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer. Clinical Cancer Research. 10, 5981\u20135987 (2004).","journal-title":"Clinical Cancer Research."},{"key":"43520_CR53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2407-6-143","volume":"6","author":"S Mueller","year":"2006","unstructured":"Mueller, S. et al. Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments. BMC Cancer 6, 143 (2006).","journal-title":"BMC Cancer"},{"key":"43520_CR54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11899-018-0466-6","volume":"13","author":"JK Lue","year":"2018","unstructured":"Lue, J. K. & Amengual, J. E. Emerging EZH2 inhibitors and their application in lymphoma. Curr. Hematol. Malig. Rep. 13, 369\u2013382 (2018).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"43520_CR55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cell.2012.09.002","volume":"151","author":"P Voigt","year":"2012","unstructured":"Voigt, P. et al. Asymmetrically modified nucleosomes. Cell 151, 181\u2013193 (2012).","journal-title":"Cell"},{"key":"43520_CR56","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/bcr3681","volume":"16","author":"Y Yokoyama","year":"2014","unstructured":"Yokoyama, Y. et al. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity. Breast Cancer Res. 16, R66 (2014).","journal-title":"Breast Cancer Res."},{"key":"43520_CR57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13059-016-1017-x","volume":"17","author":"DM Nelson","year":"2016","unstructured":"Nelson, D. M. et al. Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability. Genome Biol. 17, 158 (2016).","journal-title":"Genome Biol."},{"key":"43520_CR58","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/cancers11050723","volume":"11","author":"R Noberini","year":"2019","unstructured":"Noberini, R. et al. Profiling of epigenetic features in clinical samples reveals novel widespread changes in cancer. Cancers (Basel) 11, 723 (2019).","journal-title":"Cancers (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43520-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43520-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43520-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:24:38Z","timestamp":1700267078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43520-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43520"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-43520-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are employed by Volition.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16335"}}